東和薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/11/10 | 2,941 | 2,957 | 2,901 | 2,941 | -3 | -0.1% | 113,600 |
| 2021/11/09 | 2,962 | 2,981 | 2,930 | 2,944 | -39 | -1.3% | 68,700 |
| 2021/11/08 | 2,964 | 2,987 | 2,954 | 2,983 | +49 | +1.7% | 91,900 |
| 2021/11/05 | 2,916 | 2,936 | 2,881 | 2,934 | +15 | +0.5% | 79,900 |
| 2021/11/04 | 2,942 | 2,949 | 2,895 | 2,919 | +11 | +0.4% | 126,400 |
| 2021/11/02 | 2,970 | 2,973 | 2,908 | 2,908 | -43 | -1.5% | 104,700 |
| 2021/11/01 | 2,960 | 2,963 | 2,899 | 2,951 | +26 | +0.9% | 160,600 |
| 2021/10/29 | 2,970 | 2,970 | 2,907 | 2,925 | -42 | -1.4% | 171,600 |
| 2021/10/28 | 3,015 | 3,050 | 2,962 | 2,967 | -93 | -3% | 222,600 |
| 2021/10/27 | 3,295 | 3,305 | 3,055 | 3,060 | -335 | -9.9% | 438,500 |
| 2021/10/26 | 3,465 | 3,485 | 3,380 | 3,395 | -65 | -1.9% | 80,200 |
| 2021/10/25 | 3,540 | 3,560 | 3,450 | 3,460 | -80 | -2.3% | 119,200 |
| 2021/10/22 | 3,495 | 3,540 | 3,495 | 3,540 | +55 | +1.6% | 68,800 |
| 2021/10/21 | 3,480 | 3,500 | 3,465 | 3,485 | +35 | +1% | 69,500 |
| 2021/10/20 | 3,445 | 3,470 | 3,415 | 3,450 | +40 | +1.2% | 59,000 |
| 2021/10/19 | 3,390 | 3,435 | 3,370 | 3,410 | +35 | +1% | 46,800 |
| 2021/10/18 | 3,435 | 3,445 | 3,315 | 3,375 | -55 | -1.6% | 77,000 |
| 2021/10/15 | 3,360 | 3,440 | 3,360 | 3,430 | +95 | +2.8% | 79,200 |
| 2021/10/14 | 3,325 | 3,335 | 3,300 | 3,335 | +5 | +0.2% | 35,200 |
| 2021/10/13 | 3,345 | 3,365 | 3,310 | 3,330 | +10 | +0.3% | 68,400 |
| 2021/10/12 | 3,345 | 3,350 | 3,300 | 3,320 | -20 | -0.6% | 48,200 |
| 2021/10/11 | 3,290 | 3,340 | 3,260 | 3,340 | +100 | +3.1% | 71,900 |
| 2021/10/08 | 3,250 | 3,270 | 3,210 | 3,240 | +70 | +2.2% | 55,600 |
| 2021/10/07 | 3,200 | 3,240 | 3,170 | 3,170 | -40 | -1.2% | 47,100 |
| 2021/10/06 | 3,175 | 3,240 | 3,160 | 3,210 | +25 | +0.8% | 84,500 |
| 2021/10/05 | 3,215 | 3,240 | 3,145 | 3,185 | -70 | -2.2% | 75,700 |
| 2021/10/04 | 3,290 | 3,300 | 3,220 | 3,255 | +75 | +2.4% | 113,300 |
| 2021/10/01 | 3,165 | 3,205 | 3,150 | 3,180 | +10 | +0.3% | 81,900 |
| 2021/09/30 | 3,205 | 3,240 | 3,170 | 3,170 | -25 | -0.8% | 110,500 |
| 2021/09/29 | 3,170 | 3,195 | 3,120 | 3,195 | -60 | -1.8% | 134,600 |
| 2021/09/28 | 3,270 | 3,275 | 3,210 | 3,255 | -5 | -0.2% | 246,400 |
| 2021/09/27 | 3,305 | 3,330 | 3,255 | 3,260 | -10 | -0.3% | 108,200 |
| 2021/09/24 | 3,300 | 3,300 | 3,255 | 3,270 | +40 | +1.2% | 88,700 |
| 2021/09/22 | 3,310 | 3,310 | 3,225 | 3,230 | -100 | -3% | 63,900 |
| 2021/09/21 | 3,330 | 3,375 | 3,300 | 3,330 | ±0 | ±0% | 108,900 |
| 2021/09/17 | 3,370 | 3,370 | 3,285 | 3,330 | -50 | -1.5% | 124,600 |
| 2021/09/16 | 3,370 | 3,395 | 3,345 | 3,380 | -5 | -0.1% | 92,600 |
| 2021/09/15 | 3,300 | 3,385 | 3,295 | 3,385 | +35 | +1% | 92,700 |
| 2021/09/14 | 3,325 | 3,350 | 3,300 | 3,350 | +35 | +1.1% | 85,300 |
| 2021/09/13 | 3,255 | 3,330 | 3,245 | 3,315 | +50 | +1.5% | 70,700 |
| 2021/09/10 | 3,240 | 3,265 | 3,215 | 3,265 | +15 | +0.5% | 84,600 |
| 2021/09/09 | 3,240 | 3,260 | 3,220 | 3,250 | +10 | +0.3% | 94,900 |
| 2021/09/08 | 3,170 | 3,240 | 3,165 | 3,240 | +85 | +2.7% | 123,300 |
| 2021/09/07 | 3,170 | 3,200 | 3,140 | 3,155 | -25 | -0.8% | 83,600 |
| 2021/09/06 | 3,180 | 3,190 | 3,145 | 3,180 | +35 | +1.1% | 66,300 |
| 2021/09/03 | 3,105 | 3,160 | 3,080 | 3,145 | +80 | +2.6% | 100,200 |
| 2021/09/02 | 3,040 | 3,065 | 3,010 | 3,065 | ±0 | ±0% | 79,100 |
| 2021/09/01 | 2,995 | 3,070 | 2,985 | 3,065 | +113 | +3.8% | 114,000 |
| 2021/08/31 | 2,935 | 2,981 | 2,932 | 2,952 | +10 | +0.3% | 119,900 |
| 2021/08/30 | 2,887 | 2,956 | 2,887 | 2,942 | +55 | +1.9% | 356,900 |
851～
900
件表示中 / 6945件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 東和薬品 | 263,700円 | +15.0% | -7.3% | 2.65% | 8.65倍 | 0.82倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| サンバイオ | 229,900円 | - | - | 0.00% | - | 106.48倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 鳥居薬 | 523,000円 | +7.1% | -35.0% | 2.29% | 43.25倍 | 1.21倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 234,300円 | +14.2% | +41.0% | 1.96% | 11.48倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ジーエヌアイ | 241,500円 | +21.7% | +999.9% | 0.00% | 10.06倍 | 3.33倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
